<DOC>
	<DOCNO>NCT00381108</DOCNO>
	<brief_summary>To determine whether pomegranate tablet therapeutic effect Benign Prostatic Hyperplasia .</brief_summary>
	<brief_title>Study Effects Pomegranate Tablets Enlarged Prostates</brief_title>
	<detailed_description>Patients newly diagnose benign prostatic hyperplasia ( BPH ) recruit urology clinic UCI medical center study indicate section 4 . Once recruit , patient randomize two group - placebo pomegranate tablet . Prior randomization , 6 week run-in period basal parameter establish . The basal parameter include complete history physical exam include AUA symptom questionnaire men 's sexual health questionnaire , urine culture , urinalysis , PSA , serum chemistry ( sodium , potassium , chloride , bicarbonate , BUN , creatinine , glucose ) , serum free testosterone , serum dihydrotestosterone , maximum urinary flow rate ( Qmax ) , post void residual bladder volume , prostate volume measurement via Trans-rectal ultrasound . Then patient randomize either study group control group use random number generator . All study subject counsel take one capsule daily morning consume prostate supplement , form medical herbal therapy BPH . Patients ask come every 2 month follow test questionnaire administer : 1 . AUA Symptoms Score sheet 2 . Men 's Sexual Health Questionnaire 3 . Urine culture 4 . Urinalysis 5 . PSA 6 . Serum chemistry ( sodium , potassium , chloride , bicarbonate , BUN , creatinine , glucose ) 7 . Serum free testosterone 8 . Serum 5-dihydrotestosterone 9 . Maximum urinary flow rate ( Qmax ) 10 . Post void residual check 11 . Prostate volume measurement via Trans-rectal ultrasound Maximum blood volume draw blood draw 10 ml ( 2 table spoon ) , maximum blood draw per patient 3 per person crossover 6 crossover . Prior blood draw , patient ask refrain sexual intercourse least 48 hr . Patients severe BPH ( AUA symptom score 20 ) already form medical therapy prescription finasteride , terazosin , tamsulosin , propecia ( hair loss ) history prostate surgery eligible participate study . Also , patient take non prescription supplement Saw Palmetto , B-sitosterol , vitamin E , quercetin , include study . One group ( n = 10 ) take pomegranate tablet . Group 2 ( n = 10 ) take 1 placebo tablet morning daily . Both pomegranate tablet placebo provide Pomegranate Health Company . Prior randomization , 6-week run-in time void parameter notoriously variable . During run-in time , patient ask return clinic every two week measure maximum urinary flow post-void residual bladder volume . After six-month period , subject cross individually placebo active treatment , active treatment placebo . The total anticipated timeline study 12 month . If early termination study request final evaluation give . The final evaluation study entail standard office visit blood collection final AUA symptom score Men 's sexual health questionnaire , transrectal ultrasound prostate measure parameter previous office visit . Subsequently , recommendation make urologist regard standard treatment option BPH .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>18 year age old Clinically diagnose mild moderate BPH ( AUA symptom score &lt; 20 ) Patient severe BPH ( AUA symptom score &gt; 21 ) Currently use form medical therapy , prescription finasteride , terazosin , tamsulosin propecia ( hair loss ) . Prior Transurethral resection prostate ( TURP ) . Using nonprescription supplement Saw Palmetto , Bsitosterol , vitamin E , quercetin .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>BPH</keyword>
</DOC>